click below
click below
Normal Size Small Size show me how
Micro Unit Three
Question | Answer |
---|---|
Pre-Vaccine. Gives a small dose of disease to help person build immunity. | Variolation |
Weakened Pathogen. Uses whole, live microbe. >95% effective. (I.e. Measles, Mumps, and Rubella Vaccine) | Attenuated Whole Agent |
Uses killed microbe (I.e. Influenza) | Inactivated Whole Agent Vaccine |
Inactivated toxins (I.e. Tetanus) | Toxoids |
Use only antigenic fragment of a microorganism that best stimulates an immune response. Produced by modifying other microbes to produce the desired fragments (I.e. Hepatitis B) | Sub-unit Vaccine |
Used to deal with children with a poor/weak immune response (I.e. Very young infants) | Conjugate Vaccine |
New experimental vaccines. Can be given without needles. Given with gene gun. | Nucleus Acid/DNA Vaccines |
Probability that a diagnostic test is reactive if specimen is a true positive. | Sensitivity |
Probability that a positive diagnostic test will not be reactive if specimen is a true negative. | Specificity |
Antigen reacts with antibodies to create lattice structure forming a precipitate | Precipitation Rxn |
A test performed on an agar plate requiring the correct concentration of antigens an antibodies | Immunodiffusion Test |
Precipitation test used for large cellular antigens like RBCs | Direct Agglutination Test |
Precipitation test used for small and soluble antigens. | Indirect Agglutination Test |
Precipitation test used for blood typing | Hemagglutination Test |
Precipitation test that combines fluorescent dyes with serum then exposes it to UV light. | Fluorescent Antibody Technique |
Direct and Indirect test for blood in urine | Enzyme Linked Immunosorbent Assay (ELISA) D |
A hypersensitivity rxn seen 2-30 minutes after exposure to antigen. Characterized by IgE antibodies binding to basophil+mast cells. | Type I Anaphylactic |
A hypersensitivity rxn seen approximately 5-12 hours after exposure to antigen characterized by IgG and IgM antibodies binding to target cells to activate the complement system | Type II Cytotoxic |
A hypersensitivity rxn seen approximately 3-8 hours after exposure to antigen characterized by antibody+antigen complex which can cause damaging inflammation | Type III Immune Complex |
A hypersensitivity rxn seen approximately 24-48 hours after exposure to antigen characterized by the utilization of Cytotoxic T-cells | Type IV Delayed Cell-mediated |
A potential pregnancy complication caused by the mother having a negative blood type and the father having a positive blood type | Hemolytic Disease of the Newborn |
Define: Hybridoma (A.K.A. Monoclonal Antibodies) | Cancer cell+ B-cell that is used in diagnostic test |
Define: Antibiotic | A substance produced by microorganisms that, in small amounts, inhibit another microorganism. |
Define: Bactericidal | An anti-microbial agent that works by killing bacteria directly |
Define: Bacteriostatic | An anti-microbial agent that inhibits growth of bacteria, which allows the body's immune system to kill the pathogen |